OVERVIEW
The market size of the NGS-based RNA sequencing is projected to reach USD 5.02 billion by 2025, rising at a CAGR of 19.4% over the 2020-2025 forecast period. Market growth is primarily driven by the advantages of RNA-seq over traditional technologies; increasing numbers of RNA-seq grants; rising numbers of RNA-seq research activities; and rapid growth in the market for precision medicines.
TABLE OF CONTENT
1 Global NGS-Based RNA-Sequencing Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global NGS-Based RNA-Sequencing Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global NGS-Based RNA-Sequencing Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global NGS-Based RNA-Sequencing Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global NGS-Based RNA-Sequencing Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global NGS-Based RNA-Sequencing Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global NGS-Based RNA-Sequencing Market – By Product & Service (Market Size – &
million/billion)
8.1 Sample Preparation Products
8.2 Sequencing Platforms & Consumables
8.3 Sequencing Services
8.4 Data Analysis, Storage, & Management
9 Global NGS-Based RNA-Sequencing Market – By Technology
9.1 Sequencing by Synthesis
9.2 Nanopore Sequencing
9.3 Ion Semiconductor Sequencing
9.4 Single-molecule Real-time Sequencing
10 Global NGS-Based RNA-Sequencing Market – By Application
10.1 Variant Calling & Transcriptome Epigenetics
10.2 Expression Profiling Analysis
10.3 Small RNA Sequencing
10.4 De Novo Transcriptome Assembly
11 Global NGS-Based RNA-Sequencing Market – By End User
11.1 Research & Academia
11.2 Hospitals & Clinics
11.3 Pharmaceutical & Biotechnology
11.4 Other
12 Global NGS-Based RNA-Sequencing Market – By Geography (Market Size – &
million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global NGS-Based RNA-Sequencing Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global NGS-Based RNA-Sequencing Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Agilent Technologies
14.3 BGI Group
14.4 Hamilton Company
14.5 Illumina
14.6 Eurofins Scientific
14.7 Perkinelmer
14.8 Psomagen
14.9 GENEWIZ (Part of Brooks Automation)
14.10 Nugen Technologies (Part of Tecan Trading AG)
14.11 Oxford Nanopore Technologies
14.12 Company 11 & more
15 Global NGS-Based RNA-Sequencing Market – Appendix
15.1 Sources
15.2 Abbreviations